combination

Read news on combination with our app.

Read more in the app

‘Smart bomb’ combination attacks triple-negative breast cancer in preclinical study

OU researcher to study CAR T-cell and opaganib combination in clinical trials for ultra-high-risk multiple myeloma

Combination nucleic acid therapies: towards personalized cancer treatment

Early-Onset Type 2 Diabetes Went Into Remission in More Than Half of People on This 24-Week Program

Why are dengue cases surging in Florida this year? An 'unlucky' combination of factors, experts say

Emerging glioblastoma therapies move toward biomarker-guided and combination strategies

Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer - EurekAlert!

A combination of five-mRNAs mitigates heart failure after myocardial infarction - EurekAlert!

Measuring shame through a combination of self-report, language and body posture may be clinically helpful - EurekAlert!

Dana-Farber Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies - EurekAlert!

A Combination of Techniques Leads to Improved Friction Stir Welding

Combination of two quantum materials achieves unprecedented control over electron spin - EurekAlert!

Wood relaxes even in virtual form – A combination of scent and visual stimuli boosts recovery - EurekAlert!

HIV antibody opens up new approaches for vaccine development and combination therapies - EurekAlert!

Combination pills for high blood pressure may simplify treatment, improve long-term health - EurekAlert!

It’s now possible to create convincing real-time audio deepfakes using a combination of publicly available tools and affordable hardware

Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer - EurekAlert!

Combination of two drugs that fight cardiovascular risk could also help treat the most common liver disease - EurekAlert!

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds - EurekAlert!

Combination of mini-camera and AI predicts recurrent heart attack - EurekAlert!